# Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate

> **NCT03531749** · NA · COMPLETED · sponsor: **Universidad Autónoma del Estado de Hidalgo** · enrollment: 60 (actual)

## Conditions studied

- HIV Positive

## Interventions

- **DIETARY_SUPPLEMENT:** HIV+ MRPJ
- **DIETARY_SUPPLEMENT:** HIV+ ascorbic acid

## Key facts

- **NCT ID:** NCT03531749
- **Lead sponsor:** Universidad Autónoma del Estado de Hidalgo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03531749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03531749, "Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03531749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*